Mild Cognitive Impairment Clinical Trial
Official title:
Effect of Heat Exposure on Cognition in Persons With Higher Cord Lesions
Verified date | November 2019 |
Source | VA Office of Research and Development |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The ability to maintain normal body temperature (Tcore) is impaired in persons with
tetraplegia: subnormal Tcore and vulnerability to hypothermia (<95 F) have been documented in
this population after exposure to even mild environmental temperatures. However, no work to
date has addressed the effect of subnormal Tcore on cognitive performance in persons with
tetraplegia despite studies with able-bodied (AB) individuals that have documented
progressive decline in various aspects of cognitive performance associated with the magnitude
of the depression in Tcore. The investigators' study will confirm and extend their initial
observations in persons with higher cord lesions who have subnormal Tcore to show that
cognitive performance will be improved by raising Tcore to euthermic levels. This improvement
should be associated with greater function and independence, reintegration into society, and
an improved quality of life.
Specific Aims: During exposure to 95 F for up to 120 minutes in the seated position, the
investigators' aims are:
Primary Specific Aim: To determine if a modest rise in Tcore to euthermic levels has a
positive effect on cognitive performance (attention, working memory, processing speed, and
executive function) in persons with higher-level spinal cord injury (SCI).
Primary Hypothesis: Based on the investigators' pilot data: (1) 80% of persons with SCI will
demonstrate an increase of 1 F in Tcore, while none of the AB controls will demonstrate such
an increase; (2) 80% of persons with SCI will have an improvement of at least one T-score in
Stroop Interference scores (a validated measure of executive function), while none of the AB
controls will demonstrate a change in cognitive performance.
Secondary Specific Aim: To determine changes in: (1) The average of distal skin temperatures;
(2) Sweat rate; and (3) Subjective rating of thermal sensitivity.
Secondary Hypothesis: Persons with SCI will have less of a percent change in average distal
skin temperatures and sweat rate, and will report blunted ratings of thermal sensitivity
compared to that of AB controls.
Status | Completed |
Enrollment | 41 |
Est. completion date | September 4, 2018 |
Est. primary completion date | September 4, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 68 Years |
Eligibility |
Inclusion Criteria: - Duration of injury 1 year - Level of SCI C3-T4, AIS A & B - Tcore at BL <98.6 F (subnormal core body temperature) - Euhydration - Gender and age-matched ( 5 years) AB controls (between 18-68 years of age) Exclusion Criteria: - Known heart, kidney, peripheral vascular, or cerebral vascular disease - High blood pressure - History of traumatic brain injury or diagnosed cognitive impairment - Untreated thyroid disease - Diabetes mellitus - Acute illness or infection - Dehydration - Smoking - Pregnancy - Broken, inflamed, or otherwise fragile skin |
Country | Name | City | State |
---|---|---|---|
United States | James J. Peters VA Medical Center, Bronx, NY | Bronx | New York |
Lead Sponsor | Collaborator |
---|---|
VA Office of Research and Development | James J. Peters Veterans Affairs Medical Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Core Body Temperature From Baseline to 120 Minutes Post Warm Challenge | The investigators measured the effects of warm temperature (95 F) exposure, of up to 120 minutes, on the ability to maintain a constant body temperature (e.g., core temperature of 98.6 F) in both groups of subjects. Core temperature was measured at baseline (thermoneutral) and after 120 minutes of warm temperature exposure (Warm Challenge). The change in core temperature from baseline to 120 minutes of Warm Challenge was calculated. | From Baseline to 120 Minutes | |
Primary | Change in Cognitive Performance From Baseline to 120 Minutes Post Warm Challenge | Cognitive performance was assessed using a neuropsychological battery. Cognitive performance was assessed at 2 time points, at the end of baseline and after heat exposure (warm challenge) in both groups of subjects. The Stroop Word test measures processing speed. A T-Score of 50 means "0" difference of actual - predicted score (based on subject's age & education level). T-Scores <40 are considered "low"; T-Scores >40 are considered "normal". Changes of 10 or greater are considered clinically significant. The lowest possible T-Score is 21; the highest possible T-Score is 80. The WAIS-IV Digit Span Sequencing measures auditory processing and working memory. Each test score is converted to a scaled score (M=10, SD=3) with higher scores considered better performance. The lowest possible scaled score is 1; the highest possible scaled score is 19. |
From Baseline to 120 Minutes | |
Secondary | Change in Distal Skin Temperatures From Baseline to 120 Minutes Post Warm Challenge | The investigators measured the effects of warm temperature (95 F) exposure, of up to 120 minutes, on the change in distal skin temperatures in the seated position. | From Baseline to 120 Minutes | |
Secondary | Change in Sweat Rate From Baseline to 120 Minutes Post Warm Challenge | The investigators measured the effects of warm temperature (95 F) exposure, of up to 120 minutes, on the change in sweat rate in the seated position. | From Baseline to 120 Minutes | |
Secondary | Change in Thermal Sensitivity From Baseline to 120 Minutes Post Warm Challenge | The investigators measured the effects of warm temperature (95 F) exposure, of up to 120 minutes, on the change in thermal sensitivity in the seated position on the 9-Point Thermal sensation scale (+4=very hot, +3=hot, +2=warm, +1=slightly warm, 0=neutral, -1=slightly cool, -2=cool, -3=cold, -4=very cold). A higher score means the subject feels hotter, which, for the identical heat challenge, means less effective thermoregulation. | From Baseline to 120 Minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04513106 -
Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial
|
N/A | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Active, not recruiting |
NCT03167840 -
Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment
|
N/A | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Not yet recruiting |
NCT05041790 -
A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment
|
Phase 4 | |
Recruiting |
NCT04121156 -
High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT03605381 -
MORbidity PRevalence Estimate In StrokE
|
||
Completed |
NCT02774083 -
Cognitive Training Using Feuerstein Instrumental Enrichment
|
N/A | |
Completed |
NCT01315639 -
New Biomarker for Alzheimer's Disease Diagnostic
|
N/A | |
Enrolling by invitation |
NCT06023446 -
Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
|
||
Completed |
NCT04567745 -
Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers
|
Phase 1 | |
Recruiting |
NCT05579236 -
Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
|
||
Completed |
NCT03583879 -
Using Gait Robotics to Improve Symptoms of Parkinson's Disease
|
N/A | |
Terminated |
NCT02503501 -
Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
|
Phase 2 | |
Not yet recruiting |
NCT03740178 -
Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)
|
Phase 1 | |
Active, not recruiting |
NCT05204940 -
Longitudinal Observational Biomarker Study
|
||
Recruiting |
NCT02663531 -
Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease
|
N/A | |
Recruiting |
NCT06150352 -
Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
|
||
Recruiting |
NCT03507192 -
Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia.
|
N/A |